Free Trial

American Century Companies Inc. Buys 11,385 Shares of Ibotta, Inc. $IBTA

Ibotta logo with Business Services background

Key Points

  • American Century Companies Inc. increased its stake in Ibotta, Inc. by 26.5% in Q1, now holding approximately 0.18% of the company valued at $2.29 million.
  • Several institutional investors, including GAMMA Investing LLC and Sumitomo Mitsui Trust Group Inc., also significantly increased their holdings in Ibotta during the same quarter.
  • Ibotta's stock was affected by recent downgrades from analysts, with a consensus rating of "Hold" and a target price drop to $34.71.
  • MarketBeat previews top five stocks to own in October.

American Century Companies Inc. raised its holdings in Ibotta, Inc. (NYSE:IBTA - Free Report) by 26.5% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 54,326 shares of the company's stock after buying an additional 11,385 shares during the quarter. American Century Companies Inc. owned 0.18% of Ibotta worth $2,293,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of IBTA. Nikko Asset Management Americas Inc. grew its holdings in Ibotta by 68.8% during the first quarter. Nikko Asset Management Americas Inc. now owns 1,053,518 shares of the company's stock worth $44,458,000 after buying an additional 429,516 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. grew its stake in Ibotta by 67.2% in the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,043,758 shares of the company's stock valued at $44,047,000 after purchasing an additional 419,516 shares during the period. ARK Investment Management LLC lifted its position in shares of Ibotta by 299.8% during the 1st quarter. ARK Investment Management LLC now owns 704,308 shares of the company's stock valued at $29,722,000 after buying an additional 528,147 shares during the last quarter. Citigroup Inc. lifted its position in shares of Ibotta by 2,500.8% during the 1st quarter. Citigroup Inc. now owns 334,460 shares of the company's stock valued at $14,114,000 after buying an additional 321,600 shares during the last quarter. Finally, Pacer Advisors Inc. purchased a new position in shares of Ibotta during the 1st quarter valued at $3,539,000.

Ibotta Price Performance

Shares of NYSE:IBTA traded down $0.13 on Thursday, hitting $25.97. The company's stock had a trading volume of 152,807 shares, compared to its average volume of 462,781. The company has a 50-day simple moving average of $33.42 and a 200 day simple moving average of $44.15. Ibotta, Inc. has a 1 year low of $22.50 and a 1 year high of $79.80. The company has a market capitalization of $656.03 million, a PE ratio of 9.02, a PEG ratio of 21.55 and a beta of -1.31.

Ibotta declared that its board has initiated a stock repurchase program on Monday, June 9th that authorizes the company to buyback $100.00 million in outstanding shares. This buyback authorization authorizes the company to purchase up to 8.5% of its stock through open market purchases. Stock buyback programs are generally an indication that the company's board of directors believes its shares are undervalued.

Insider Activity

In other news, CMO Richard I. Donahue sold 85,289 shares of the stock in a transaction dated Thursday, June 12th. The stock was sold at an average price of $43.09, for a total transaction of $3,675,103.01. Following the transaction, the chief marketing officer directly owned 199,773 shares in the company, valued at approximately $8,608,218.57. This represents a 29.92% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, major shareholder Jermoluk Founders Fund I. Clark sold 1,578,502 shares of the stock in a transaction dated Thursday, June 26th. The shares were sold at an average price of $35.00, for a total value of $55,247,570.00. Following the transaction, the insider owned 3,841,308 shares in the company, valued at $134,445,780. This trade represents a 29.12% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 2,122,669 shares of company stock worth $75,183,931 over the last quarter. Corporate insiders own 16.08% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on IBTA. JMP Securities reissued a "market perform" rating on shares of Ibotta in a report on Thursday, August 14th. Citizens Jmp cut Ibotta from an "outperform" rating to a "market perform" rating in a report on Thursday, August 14th. Citigroup cut Ibotta from a "buy" rating to a "market perform" rating in a report on Thursday, August 14th. The Goldman Sachs Group cut Ibotta from a "buy" rating to a "neutral" rating and dropped their price objective for the stock from $58.00 to $30.00 in a report on Thursday, August 14th. Finally, Needham & Company LLC dropped their price objective on Ibotta from $70.00 to $33.00 and set a "buy" rating on the stock in a report on Thursday, August 14th. One analyst has rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $34.71.

Read Our Latest Report on IBTA

About Ibotta

(Free Report)

Ibotta's mission is to Make Every Purchase Rewarding. Our technology allows CPG brands to deliver digital promotions to over 200 million consumers through a single, convenient network called the Ibotta Performance Network (IPN). We are pioneers in success-based marketing: we only get paid when our client's promotion results in a sale, not when a consumer merely views or clicks on the promotion.

Further Reading

Institutional Ownership by Quarter for Ibotta (NYSE:IBTA)

Should You Invest $1,000 in Ibotta Right Now?

Before you consider Ibotta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ibotta wasn't on the list.

While Ibotta currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report
Like this article? Share it with a colleague.